Discovery of Orally Bioavailable 1,3,4-Trisubstituted 2-Oxopiperazine-Based Melanocortin-4 Receptor Agonists as Potential Antiobesity Agents
Year: 2008
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/jm800525p
Authors: Xinrong Tian, Adrian G. Switzer, Steve A. Derose, Rajesh K. Mishra, Mark G. Solinsky, Rashid N. Mumin, Frank H. Ebetino, Lalith R. Jayasinghe, Mark E. Webster, Anny-Odile Colson, Doreen Crossdoersen, Beth B. Pinney, Julie A. Farmer, Martin E. Dowty, Cindy M. Obringer, Charles A. Cruze, Melissa L. Burklow, Paula M. Suchanek, Lily Dong, Mary Kay Dirr, Russell J. Sheldon, John A. Wos
Institution: Procter & Gamble (United States)
Language: English
Subfield: Endocrine and Autonomic Systems
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2052103950
